Universal Health Services
About: Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Employees: 99,000
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
79% more call options, than puts
Call options by funds: $63.7M | Put options by funds: $35.6M
2.89% more ownership
Funds ownership: 88.88% [Q3] → 91.77% (+2.89%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]
9% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 107
10% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 221
3% less funds holding
Funds holding: 613 [Q3] → 594 (-19) [Q4]
20% less capital invested
Capital invested by funds: $12.1B [Q3] → $9.67B (-$2.42B) [Q4]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$200
10%
upside
Avg. target
$219
20%
upside
High target
$257
41%
upside
8 analyst ratings
3 positive
38%
5 neutral
63%
0 negative
0%
RBC Capital Ben Hendrix 39% 1-year accuracy 28 / 72 met price target | 11%upside $201 | Sector Perform Maintained | 30 Apr 2025 |
Barclays Andrew Mok 44% 1-year accuracy 27 / 61 met price target | 41%upside $257 | Overweight Maintained | 29 Apr 2025 |
Baird Michael Ha 43% 1-year accuracy 10 / 23 met price target | 23%upside $224 | Neutral Downgraded | 15 Apr 2025 |
Guggenheim Jason Cassorla 40% 1-year accuracy 6 / 15 met price target | 14%upside $208 | Buy Initiated | 9 Apr 2025 |
Morgan Stanley Craig Hettenbach 38% 1-year accuracy 3 / 8 met price target | 10%upside $200 | Equal-Weight Initiated | 26 Mar 2025 |
Financial journalist opinion
Based on 23 articles about UHS published over the past 30 days
Positive
Zacks Investment Research
2 days ago
Why Universal Health Services (UHS) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
3 days ago
Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
6 days ago
Universal Health Services (UHS) Upgraded to Buy: Here's Why
Universal Health Services (UHS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Zacks Investment Research
6 days ago
Does Universal Health Services (UHS) Have the Potential to Rally 26.33% as Wall Street Analysts Expect?
The mean of analysts' price targets for Universal Health Services (UHS) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Positive
Zacks Investment Research
1 week ago
Best Growth Stocks to Buy for April 30th
LMB, UHS and BGC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 30, 2025.
Neutral
Seeking Alpha
1 week ago
Universal Health Services, Inc. (UHS) Q1 2025 Earnings Call Transcript
Universal Health Services, Inc. (NYSE:UHS ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - Chief Executive Officer Conference Call Participants Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Stephen Baxter - Wells Fargo Benjamin Rossi - JPMorgan Joshua Raskin - Nephron Research Craig Hettenbach - Morgan Stanley Matthew Gillmor - KeyBanc Capital Markets Michael Ha - Baird Pito Chickering - Deutsche Bank Ryan Langston - TD Cowen Joanna Gajuk - Bank of America A.J. Rice - UBS Operator Good day and thank you for standing by.
Positive
Zacks Investment Research
1 week ago
Best Growth Stocks to Buy for April 29th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today April 29th:
Neutral
Zacks Investment Research
1 week ago
Universal Health Q1 Earnings Beat on Strong Acute Care Admissions
UHS continues to witness growth in acute care facilities' patient days, while behavioral health care services witness decline.
Positive
Zacks Investment Research
1 week ago
Universal Health Services (UHS) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
1 week ago
Universal Health Services (UHS) Q1 Earnings Top Estimates
Universal Health Services (UHS) came out with quarterly earnings of $4.84 per share, beating the Zacks Consensus Estimate of $4.36 per share. This compares to earnings of $3.70 per share a year ago.
Charts implemented using Lightweight Charts™